Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Endocrine 1

Conditions

Prostatic Neoplasms 250 Carcinoma, Renal Cell 89 Urinary Bladder Neoplasms 67 Breast Neoplasms 41 Carcinoma, Transitional Cell 37 Colorectal Neoplasms 33 Ovarian Neoplasms 32 Melanoma 31 Carcinoma, Non-Small-Cell Lung 31 Kidney Neoplasms 30 Neoplasms 28 Neoplasm Metastasis 26 Sarcoma 25 Uterine Cervical Neoplasms 20 Lung Neoplasms 20 Endometrial Neoplasms 20 Non-Muscle Invasive Bladder Neoplasms 19 Wilms Tumor 17 Adenocarcinoma 17 Stomach Neoplasms 16 Pancreatic Neoplasms 16 Carcinoma, Hepatocellular 16 Triple Negative Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Metastatic Castration-resistant Prostate Cancer 13 Esophageal Neoplasms 13 Rhabdomyosarcoma 12 Osteosarcoma 12 Neuroblastoma 12 Head and Neck Neoplasms 12

Interventions

salicylhydroxamic acid 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Postoperative × Genitourinary × 30 days × Clear all

NCT04085237 2026-06-04

ESPB

McMaster University

Phase NA Terminated

Kidney Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡